Top-News
Professionelle Dienstleistungen Schweiz

Spexis News

Aktie
WKN:  A2JK4Q ISIN:  CH0106213793 US-Symbol:  PPHOF
0,0542 CHF
-0,0096 CHF
-15,05%
03.05.24 15:52:07
Handeln Depot/Watchlist
Aktienanzahl *
58,71 Mio.
Marktkapitalisierung *
3,52 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 18.01.2024

Spexis News

30.04.24 - DGAP
Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. 
Spexis AG / Key word(s): Miscellaneous Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May ...
17.04.24 - DGAP
Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
Spexis AG / Key word(s): Miscellaneous Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and ...
08.02.24 - DGAP
Spexis announces closing of sale of preclinical antibiotics program to Basilea
Spexis AG / Key word(s): Miscellaneous Spexis announces closing of sale of preclinical antibiotics program to Basilea 08-Feb-2024 / 07:15 CET/CEST Release of an ad hoc ...
15.01.24 - DGAP
Spexis announces sale of preclinical antibiotics program to Basilea
Spexis AG / Key word(s): Disposal Spexis announces sale of preclinical antibiotics program to Basilea 15-Jan-2024 / 07:15 CET/CEST Release of an ad hoc announcement ...
05.12.23 - DGAP
Spexis is Granted Debt-Restructuring Moratorium
Spexis AG / Key word(s): Miscellaneous Spexis is Granted Debt-​Restructuring Moratorium 05-Dec-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 ...
29.11.23 - DGAP
Spexis Provides Update Regarding Debt-Restructuring Moratorium
Spexis AG / Key word(s): Miscellaneous Spexis Provides Update Regarding Debt-​Restructuring Moratorium 29-Nov-2023 / 07:15 CET/CEST Release of an ad hoc announcement ...
08.11.23 - DGAP
Spexis to file an application for a debt-restructuring moratorium
Spexis AG / Key word(s): Strategic Company Decision Spexis to file an application for a debt-​restructuring moratorium 08-Nov-2023 / 07:15 CET/CEST Release of an ad hoc ...
01.11.23 - DGAP
Spexis gibt Änderungen in der Geschäftsleitung bekannt
Spexis AG / Schlagwort(e): Personalie/Personalie Spexis gibt Änderungen in der Geschäftsleitung bekannt 01.11.2023 / 07:20 CET/CEST Veröffentlichung einer Ad-​hoc-Mitteilung ...
01.11.23 - DGAP
Spexis Announces Changes to the Executive Committee
Spexis AG / Key word(s): Personnel/Personnel Spexis Announces Changes to the Executive Committee 01-Nov-2023 / 07:20 CET/CEST Release of an ad hoc announcement ...
06.10.23 - DGAP
Spexis to host business update conference call on October 9, 2023
Spexis AG / Key word(s): Statement Spexis to host business update conference call on October 9, 2023 06.10.2023 / 07:30 CET/CEST
29.09.23 - DGAP
Spexis provides business update and announces financial results for the first half of 2023
Spexis AG / Key word(s): Half Year Results Spexis provides business update and announces financial results for the first half of 2023 29-Sep-2023 / 07:25 CET/CEST Release of an ...
28.09.23 - DGAP
Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
Spexis AG / Key word(s): Statement Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology 28.09.2023 / 07:30 CET/CEST
15.08.23 - DGAP
Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies
Spexis AG / Key word(s): Financing Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies 15-Aug-2023 / 07:25 CET/CEST ...
18.07.23 - DGAP
Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
Original-​Research: Spexis AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Spexis AG Unternehmen: Spexis AG ISIN ...
30.06.23 - DGAP
Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions
Spexis AG / Key word(s): Strategic Company Decision Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions 30-Jun-...
26.06.23 - DGAP
Spexis announces the results of its Annual General Meeting 2023
Spexis AG / Key word(s): AGMEGM Spexis announces the results of its Annual General Meeting 2023 26-Jun-2023 / 17:31 CET/CEST Release of an ad hoc announcement pursuant ...
07.06.23 - DGAP
Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances
Spexis AG / Key word(s): Scientific publication Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science ...
30.05.23 - DGAP
Spexis provides business update and announces financial results for the full year 2022
Spexis AG / Key word(s): Annual Results/Annual Results Spexis provides business update and announces financial results for the full year 2022 30-May-2023 / 07:15 CET/CEST ...
30.05.23 - DGAP
Spexis informiert über die aktuelle Geschäftsentwicklung und gibt Finanzergebnis für das Geschäftsjahr 2022 bekannt
Spexis AG / Schlagwort(e): Jahresergebnis/Jahresergebnis Spexis informiert über die aktuelle Geschäftsentwicklung und gibt Finanzergebnis für das Geschäftsjahr 2022 bekannt ...
28.04.23 - DGAP
Spexis erhält vorläufige Genehmigung für eine Ausnahme bzw. Befreiung von der Offenlegungspflicht im Zusammenhang mit der Veröffentlichung des Geschäftsberichts 2022
Spexis AG / Schlagwort(e): Jahresergebnis Spexis erhält vorläufige Genehmigung für eine Ausnahme bzw. Befreiung von der Offenlegungspflicht im Zusammenhang mit der ...

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »